Product
2E11 vg/eye of ADVM-022
1 clinical trial
2 indications
Indication
Diabetic Macular EdemaIndication
Diabetic RetinopathyClinical trial
A Phase 2, Multi-Center, Randomized, Double-Masked, Active Controlled Study of ADVM-022 (AAV.7m8-aflibercept) in Subjects With Diabetic Macular Edema [INFINITY]Status: Completed, Estimated PCD: 2022-11-22